Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maciviva is a biotechnology company focused on the development of advanced regenerative medicine therapies for cartilage repair and joint health. The company leverages tissue engineering and cell-based approaches to address significant unmet needs in orthopedic medicine, particularly for patients suffering from cartilage defects and early-stage osteoarthritis. Maciviva's core mission is to restore joint function and improve the quality of life for individuals through innovative biological solutions. While still in the early stages of its development pipeline, the company aims to translate cutting-edge research into clinical applications that offer long-term restorative benefits compared to traditional surgical interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MACIVIVA.